Home › Funds › Rivermont Capital Management LP › RGEN
Rivermont Capital Management LP position in RGEN
REPLIGEN CORP · Health Care
Rivermont Capital Management LP reported holding 190,174 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$36.6M, representing 5.20% of its reported portfolio and ranking #9 among its reported holdings. Rivermont Capital Management LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rivermont Capital Management LP's RGEN position evolved
Rivermont Capital Management LP first disclosed a stake in RGEN in Q3 2026 at 190,174 shares (US$36.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 190.17K | $36.56M | New |
About RGEN and 13F data
RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RGEN
- UNITED CAPITAL FINANCIAL ADVISORS, LLC 2.79M sh · $536.33M · Q3 2026
- Maverick Capital 1.98M sh · $270.77M · Q2 2026
- MAVERICK CAPITAL LTD 1.98M sh · $270.77M · Q2 2026
- RTW INVESTMENTS, LP 1.39M sh · $266.32M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.24M sh · $239.02M · Q3 2026
- CONGRESS ASSET MANAGEMENT CO 1.02M sh · $196.25M · Q3 2026
- Stephens Investment Management Group LLC 954.52K sh · $183.49M · Q3 2026
- WASATCH ADVISORS LP 907.16K sh · $174.38M · Q3 2026
- BAMCO INC /NY/ 740.91K sh · $142.42M · Q3 2026
- Conestoga Capital Advisors, LLC 700.63K sh · $134.68M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 591.71K sh · $113.74M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 733.74K sh · $100.11M · Q2 2026
More on Rivermont Capital Management LP
FAQ
How long has Rivermont Capital Management LP held RGEN?
Rivermont Capital Management LP has disclosed RGEN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Rivermont Capital Management LP's current position in RGEN?
As of Q3 2026, Rivermont Capital Management LP holds 190.17K shares of RGEN (REPLIGEN CORP), valued at $36.56M, representing 5.20% of its reported portfolio and ranking #9.
Has Rivermont Capital Management LP been buying or selling RGEN?
In the latest 13F filing (Q3 2026), Rivermont Capital Management LP newly opened its position in RGEN.
Which other funds hold RGEN?
Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.